Active12316036Private limited companyOxford

CAVENDISH BIOTECHNOLOGY LTD

Significant control: Cavendish Biotec Group Management Ltd (75–100%)

Companies HouseCompanies House

From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms

Watch this company

Get an email when Companies House records a change for Cavendish Biotechnology Ltd: status, filings, accounts, officers or owners. Free.

Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy

Coming soon · product and service lists

What does Cavendish Biotechnology Ltd sell?

Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.

One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01

Summary

Generated from filed data · no estimates

CAVENDISH BIOTECHNOLOGY LTD is an active private limited company (company number 12316036) incorporated on 14 November 2019, registered in Oxford. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 March 2025, showing net assets of −£71k and cash of £107, with 1 employee on average. Net assets fell 51% on the prior period (−£47k).

Peer position · net assets

By net assets it sits in the bottom quarter of 152 comparable companies in Oxford (median £10k, upper quartile £474k).

02

Ownership and control

1 active · 3 other
  • Cavendish Biotec Group Management Ltd
    corporate entity, England · since 3 April 2023
    • owns 75–100% of shares
    • holds 75–100% of voting rights
    • can appoint or remove directors
  • Mr Kevin Norville
    Individual · since 14 November 2019 · ceased 3 April 2023
    • owns 75–100% of shares
    • holds 75–100% of voting rights
    • can appoint or remove directors
  • Mr Van Greaves
    Individual · since 26 June 2020 · ceased 9 November 2021
    • owns 25–50% of shares
    • holds 25–50% of voting rights
  • Mr Stephen Laurence Hunt
    Individual · since 26 June 2020 · ceased 9 November 2021
    • owns 25–50% of shares
    • holds 25–50% of voting rights

Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.

03

Key dates

Incorporated
14 November 20196 yrs ago
Next accounts due
31 December 2026in 66 days
Confirmation statement due
28 November 2026in 33 days

Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.

04

Activity

SIC 72110
Research and experimental development on biotechnology
Accounts type
Total Exemption Full
Size band
MicroCompanies Act thresholds
05

Financials

2 periods on record · latest ending 31 March 2025
Net assets
−£71k
vs Mar 2024
Cash at bank
£107
+1%vs Mar 2024
Turnover
Not reported
Employees
1
No changevs Mar 2024
Net assets
−£71k
Cash at bank
£107
Average employees
1
Filed accounts by period, newest first
Period endNet assetsCashDebtorsCreditors <1yTurnoverProfitEmployees
31 March 2025−£71k£107£917———1
31 March 2024−£47k£106£480———1
Cash per employee£107Cash ÷ average employees

Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.

06

Filing and accounts signals

Facts from the register · no rating
  • Net assets below zeroNet assets £-71,054 at 31 March 2025
  • Net assets down 25% or more on the prior period-50.5% vs prior period
  • Incorporated five or more years agoIncorporated 14 November 2019

Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.

07

Timeline

Newest first
  1. Next accounts duein 66 days
  2. Confirmation statement duein 33 days
  3. Accounts period endNet liabilities £71k · small accounts
  4. Accounts period endNet liabilities £47k · small accounts
  5. Incorporated
08

Similar companies in Oxford

Same activity (research and experimental development on biotechnology), closest in incorporation date
09

Reminders for CAVENDISH BIOTECHNOLOGY LTD

Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.

Source: Companies House register, snapshot 2026-08-31; accounts from the Companies House accounts data product. Open Government Licence v3.0. View on Companies House. Methodology · About · Markdown.